Scarica l'app Stockscreener
2.68
2.29%
0.06
Dopo l'orario di chiusura:
2.70
0.02
+0.75%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CLOV Giù?
Forum
Previsione
Precedente Chiudi:
$2.62
Aprire:
$2.62
Volume 24 ore:
4.69M
Relative Volume:
0.69
Capitalizzazione di mercato:
$1.38B
Reddito:
$1.70B
Utile/perdita netta:
$-123.70M
Rapporto P/E:
-10.06
EPS:
-0.2663
Flusso di cassa netto:
$-178.21M
1 W Prestazione:
+2.29%
1M Prestazione:
+3.08%
6M Prestazione:
-16.77%
1 anno Prestazione:
-37.82%
Intervallo 1D:
$2.62
$2.73
Intervallo di 1 settimana:
$2.45
$2.73
Portata 52W:
$2.12
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Nome
Clover Health Investments Corp
Settore
Industria
Telefono
(201) 432-2133
Indirizzo
30 MONTGOMERY STREET, JERSEY CITY
Confronta CLOV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.68 | 1.35B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
354.47 | 315.01B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
82.68 | 103.45B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
372.24 | 82.20B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
280.39 | 73.44B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
266.29 | 32.55B | 126.36B | 1.30B | 1.55B | 10.67 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Iniziato | Craig Hallum | Buy |
| 2024-10-07 | Iniziato | UBS | Neutral |
| 2022-02-02 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-02 | Aggiornamento | Cowen | Underperform → Market Perform |
| 2022-01-19 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-01-10 | Ripresa | Citigroup | Neutral |
| 2022-01-07 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Iniziato | Cowen | Underperform |
| 2021-09-02 | Ripresa | Citigroup | Neutral |
| 2021-07-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-02-02 | Iniziato | Citigroup | Buy |
| 2021-02-01 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Clover Health Investments Corp Borsa (CLOV) Ultime notizie
Clover Health CEO Reynoso sells $11860 in shares - Investing.com
Clover Health (CLOV) Stock Trades Up, Here Is Why - Finviz
Clover Health Shares Show Momentum as Analyst Reiterates Confidence - AD HOC NEWS
CLOV Analyst Rating: Canaccord Genuity Maintains 'Buy' with Pric - GuruFocus
Canaccord Genuity Group Reiterates Buy Rating for Clover Health Investments (NASDAQ:CLOV) - MarketBeat
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now - TradingView — Track All Markets
CLOV reports MA membership growth, signals GAAP profitability in 2026 - MSN
Clover Health shares jump on 53% surge in Medicare Advantage membership - MSN
Published on: 2026-01-17 22:01:13 - baoquankhu1.vn
Traders Buy Large Volume of Put Options on Clover Health Investments (NASDAQ:CLOV) - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 - The Globe and Mail
Clover Health Investments (NASDAQ:CLOV) Shares Down 4.8%Here's Why - MarketBeat
Clover Health Investments (CLOV) Is Up 12.4% After Surging Medicare Advantage Growth And 2026 Profit Outlook – Has The Bull Case Changed? - Yahoo Finance
Clover Health Investments, Corp. (CLOV): A Bull Case Theory - Finviz
A Look At Clover Health (CLOV) Valuation After Membership Surge And First Profit Outlook - Yahoo Finance
Clover Health reports 53% Medicare Advantage growth, eyes 2026 profitability - Investing.com Nigeria
Clover Health (CLOV) Sees 11% Stock Surge on Medicare Advantage Growth - GuruFocus
Clover Health (CLOV) Reports Significant Membership Growth for 2 - GuruFocus
Clover Health (CLOV) Shares Skyrocket, What You Need To Know - Finviz
Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November - Benzinga
ex991-pressreleasedatedj.htm - SEC.gov
Clover Health Investments (NASDAQ:CLOV) Shares Gap UpTime to Buy? - MarketBeat
Clover Health Stock Is Climbing Wednesday: What's Going On? - Benzinga
Clover Health rises as Medicare Advantage enrollments climb 53% - Seeking Alpha
Clover Health stock soars after 53% Medicare Advantage membership growth - Investing.com
Clover Health stock soars after 53% Medicare Advantage membership growth By Investing.com - Investing.com Nigeria
TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday - Benzinga
Clover Health reports 53% Medicare Advantage growth, eyes 2026 profitability By Investing.com - Investing.com South Africa
Clover Health announces 53% growth in Medicare Advantage membership during AEP, increasing to 153,000 members as of January 1, 2026; expects first-ever full year GAAP net income profitability in 2026 - marketscreener.com
Clover Health Reports 53% Medicare Advantage Membership Growth and Aims for First Full Year GAAP Net Income Profitability in 2026 - Quiver Quantitative
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026 - The Manila Times
Clover Health Investments Announces 53% Growth in Medicare Advantage Membership - TradingView — Track All Markets
53% Medicare Advantage surge puts Clover Health on track for 2026 profit - Stock Titan
Aug Intraday: Why Clover Health Investments Corp stock is popular among millennialsQuarterly Performance Summary & Reliable Entry Point Trade Alerts - Bộ Nội Vụ
Counterpart Health 2025 results: how better clinical decisions at scale improve outcomes, quality, and cost - marketscreener.com
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost - The Manila Times
How an AI assistant was linked to fewer hospital stays in 2025 - Stock Titan
Assessing the Value Proposition of Clover Health Shares - AD HOC NEWS
Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Clover Health jumps 19%; options activity could be why - MSN
UnitedHealth's earnings shock is tanking the entire health insurance industry - AOL.com
Tranche Update on Clover Health Investments, Corp.'s Equity Buyback Plan announced on May 7, 2024. - MarketScreener
Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates - sharewise.com
Is Clover Health Investments Corp. stock recession proofJuly 2025 Gainers & Expert Verified Movement Alerts - ulpravda.ru
Published on: 2026-01-09 04:00:47 - Улправда
Clover Health Investments, Corp.Class A Common stock (NQ: CLOV - FinancialContent
Is Clover Health Investments Corp. stock a safe buy before earningsEarnings Beat & Technical Confirmation Alerts - ulpravda.ru
Published on: 2026-01-08 23:20:22 - ulpravda.ru
Why Clover Health Investments Corp. stock remains on buy listsTrade Ideas & High Accuracy Swing Trade Signals - ulpravda.ru
Insider Sell: Jamie Reynoso Sells Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health Investments Corp Azioni (CLOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.77%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):